Consecutive patients treated with curative intent to evaluate oncological outcomes and renal function for patients diagnosed with Primary Renal Cancer Cell [Size <7cm (cT1b)] based on TC, MRI or PET Image Study. Multifraction SBRT13Gyx3 fraction-squeme is proposed. Treatment-related toxicity is evaluated acording to CTCAE v5.
Stereotactic Body Radiotherapy (SBRT) is a non-invasive alternative to surgery to control localized primary renal cancer cell (RCC) in medically inoperable patients. Although large prospective studies are lacking, we report our institutional database of primary RCC treated with SBRT.